ITT Q2 Earnings Call Highlights

Impact · against what's priced in

ITT is seeing a significant catalyst driven by a raised full-year outlook and exceptional growth in defense-related orders via kSARIA. The acceleration of its debt reduction timeline and the scale of the SPX FLOW integration provide further fundamental support for the stock.

ITT+0.70

No priced-in read yet

In context

The company raised its full-year organic revenue outlook to 5%-8% and reported a 168% surge in kSARIA orders for defense and fighter-jet programs. Additionally, ITT hit its leverage reduction target of 2.5x six months ahead of schedule.

Read from the article alone

• m and a▲25%
• guidance▲3%
• earnings▲2%
• cash flow
• ITT
• aerospace
• biopharma